| Announce Date | 10/28/2025 | 
| EPS Normalized Actual | $2.04 (Beat by $0.46) | 
| EPS GAAP Actual | $2.04 (Beat by $0.46) | 
| Revenue Actual | $0.6875B | 
| Revenue Surprise | Beat by $687.5M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $1.6096 | 
| EPS GAAP Estimate | $1.6096 | 
| Revenue Estimate | $0.63815652B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 13.06818 | 10.86 | 12.09895 | 14.02713 | 10 | 
| Dec 2028 | 12.141 | 11.69 | 11.13499 | 15.09926 | 8 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.09 | -0.25649 | 0.6875B | 14.15% | 86.91M | 
| FQ1 2025 (Mar 2025) | 0.08 | -0.95403 | 0.5726B | 10.01% | 13.63M | 
| FQ4 2024 (Dec 2024) | 1.03 | 1.03 | 0.6277B | 17.92% | 627.7M | 
| FQ3 2024 (Sep 2024) | 1.28 | 1.28 | 0.6221B | 19.82% | 622.1M | 
| FQ2 2024 (Jun 2024) | 0.64 | 0.64 | 0.5902B | 23.3% | 590.2M | 
| FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 0.5153B | 18.42% | 515.3M | 
| FQ4 2023 (Dec 2023) | 0 | 0 | 0.5152B | 20.03% | 515.2M | 
| FQ3 2023 (Sep 2023) | 0.85 | 0.85 | 0.4988B | 22.23% | 498.8M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.6096
Consensus Revenue Estimates
0.63815652B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.708 | -- | 1.614 | 1.82718 | 6 | 
| FQ3 2027 (Sep 2027) | 1.6533 | -- | 1.6533 | 1.6533 | 6 | 
| FQ2 2027 (Jun 2027) | 1.5986 | -- | 1.5986 | 1.5986 | 6 | 
| FQ1 2027 (Mar 2027) | 1.3837 | -- | 1.30755 | 1.48025 | 9 | 
| FQ4 2026 (Dec 2026) | 3.175 | -- | 2.90928 | 3.37491 | 8 | 
| FQ3 2026 (Sep 2026) | 2.973 | -- | 2.72419 | 3.16019 | 6 | 
| FQ2 2026 (Jun 2026) | 2.8205 | 61.35 | 2.58445 | 2.99809 | 10 | 
| FQ1 2026 (Mar 2026) | 2.5277 | 96.84 | 2.31615 | 2.68685 | 6 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.83B | -- | 0.79B | 0.87B | 12 | 
| FQ3 2027 (Sep 2027) | 0.69B | -- | 0.69B | 0.69B | 12 | 
| FQ2 2027 (Jun 2027) | 0.68B | -- | 0.68B | 0.68B | 14 | 
| FQ1 2027 (Mar 2027) | 0.78B | -- | 0.75B | 0.83B | 14 | 
| FQ4 2026 (Dec 2026) | 0.89B | -- | 0.83B | 0.94B | 8 | 
| FQ3 2026 (Sep 2026) | 0.86B | -- | 0.81B | 0.9B | 8 | 
| FQ2 2026 (Jun 2026) | 0.83B | 17.15 | 0.78B | 0.87B | 12 | 
| FQ1 2026 (Mar 2026) | 0.79B | 27.71 | 0.74B | 0.83B | 8 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.34649 | 1.09 | -0.25649 | -23.53% | 
| FQ1 2025 (Mar 2025) | 1.03403 | 0.08 | -0.95403 | -1192.54% | 
| FQ4 2024 (Dec 2024) | 1.03 | 1.03 | 100% | |
| FQ3 2024 (Sep 2024) | 1.28 | 1.28 | 100% | |
| FQ2 2024 (Jun 2024) | 0.64 | 0.64 | 100% | |
| FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | 0.85 | 0.85 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.6B | $0.69B | $86.91M | 12.64% | 
| FQ1 2025 (Mar 2025) | $0.56B | $0.57B | $13.63M | 2.38% | 
| FQ4 2024 (Dec 2024) | $0B | $0.63B | $627.7M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.62B | $622.1M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $0.59B | $590.2M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.52B | $515.3M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $0.52B | $515.2M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $0.5B | $498.8M | 100% |